MYCOPHENOLATE MOFETIL

Clinical Indication

Autoimmune conditions

Comments

Please see shared care agreement for individual indications

Date of classification

June 2021

Review date

June 2021

Amber FULL SCA

Drugs which would initially be prescribed by a hospital specialist and then by a GP where full agreement to share the care of each specific patient has been reached under a LMSG Shared Care Agreement (SCA). Specific patient monitoring or intervention required.